Summary Background/Introduction: Some reports suggest early cholecystectomy for diabetic patients with asymptomatic gallstone disease (GSD) to prevent subsequent serious infection. However, only a few studies have examined the incidence of cholecystectomy in response to GSD in diabetic patients. Our study attempts to elucidate the relationship between GSD and diabetes using the high coverage rate health insurance system of Taiwan and thus evaluate the validity of early cholecystectomy in diabetic patients. Purpose(s)/Aim(s): To investigate the rate of cholecystectomy in diabetic patients with GSD. Methods: Diabetic patients without prior treatment for GSD on hospitalization or ambulatory visits were identified and compared with age-and sex-matched controls and were followed up for 8 years. Cholecystectomy incidence density rates were estimated according to the patients' diabetic status. Cox proportional hazards regression models were used to analyze the age-and sex-specific effects of diabetes on the risk of surgery for GSD. Results: The incidence rates of patients who developed GSD and underwent cholecystectomy were 18.65% and 17.15% in the diabetic and control groups, respectively; thus, the rate of cholecystectomy was higher in the diabetic group than in the control group. Male sex and old age were associated with a high rate of cholecystectomy, irrespective of the diabetic status. Hypertension, cholangitis, and Caroli disease were associated with an increased risk of cholecystectomy in patients with GSD. Overall, diabetic patients exhibited a higher incidence of cholecystectomy than nondiabetic patients did over an 8-year follow-up period. Conclusion: Men with GSD are more likely to undergo cholecystectomy than women, irrespective of the diabetic status; therefore, an aggressive GSD management approach for men must be considered for early identification of these patients before the need for emergency surgery.
Introduction
Gallstone disease (GSD) is a prevalent medical condition causing considerable economic and social burdens. Epidemiological evidence indicates that the prevalence of GSD ranges from 10% to 15%. 1 Major risk factors for GSD are old age, obesity, and female sex. Other factors associated with an increased risk of GSD are ethnicity, a high-fat or highcarbohydrate diet, estrogen use, and Gilbert's syndrome. By contrast, alcohol and coffee consumption, 1 a high-fiber diet, and statin use seem to lower the risk of GSD. Furthermore, studies have reported a higher hospital admission rate among the diabetic population. The estimated age-standardized hospital admission rate for GSD was 0.6 per 1000 persons. 2 However, since the 1990s, an increasing trend has been observed in the hospital admission rates for gallstones, which is probably caused in part by the use of improved technology, notably the use of laparoscopic cholecystectomy (LC) as a treatment option. Approximately 70e80% of all types of cholecystectomy in western countries are the LC type. Few studies have evaluated the outcome of LC in diabetic patients or the effect of diabetes-associated comorbidities on the surgical risk in these patients. Some studies have reported that diabetes predisposes patients to a high risk of conversion from LC to open cholecystectomy.
3Evidence reveals that diabetes is a risk factor for GSD, and the prevalence of GSD is higher in diabetic patients than in nondiabetic patients. In clinical settings, cholecystectomyrelated decisions regarding patients diagnosed with diabetes remain controversial, particularly in patients with asymptomatic GSD. 3 Several studies have suggested that more attention should be paid to operative and postoperative complications, GSD-associated morbidities, or both of these factors in diabetic patients, resulting in superior management and favorable outcomes in these patients. 4 Currently, little is known about the rate of cholecystectomy for GSD in diabetic patients compared with that in nondiabetic patients in the general population. An understanding of this situation in the general population may enable public health authorities to provide appropriate health care services and resources in a cost-effective manner.
Therefore, in the present study, we evaluated and compared the incidence of cholecystectomy in diabetic and nondiabetic patients with GSD.
Materials and methods

Data source
The Taiwan Department of Health incorporated health insurance programs into the Taiwan National Health Insurance (NHI) system in 1995, and the Bureau of NHI (BNHI) is contracted with 97% of hospitals as well as 90% of clinics in Taiwan. This retrospective and population-based study was conducted using data from the BNHI and National Health Research Institutes (NHRI) databases through data mining. The BNHI is the NHRI provider of Taiwan and covers approximately 98e99% of its 23 million residents. To assess the accuracy of the claims data, the BNHI performs expert quarterly reviews on a random sample of every 50e100 ambulatory and inpatient claims at each hospital and clinic and imposes severe penalties on health care providers in cases of false diagnostic reports. We analyzed the ambulatory care and inpatient claims data between 2000 and 2008 of the BNHI as well as obtained an updated registry of beneficiaries. All of the NHI datasets can be interlinked using individual personal identification numbers.
Study cohorts and comorbidities
Patients were identified on the basis of the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnostic codes in the ambulatory care claims records. Patients who received a diabetes-related diagnosis (ICD-9-CM 250) were selected for the diabetic group. A person was classified as diabetic if they had received an initial diabetes-related diagnosis at any time in the year 2000 and received subsequent diagnoses (one or more) within 12 months. The first and last outpatient visits within 1 year were more than 30 days apart to avoid the accidental inclusion of miscoded patients. To detect newly diagnosed GSD cases, patients who sought treatment at a hospital or an ambulatory care facility for gallstones (ICD-9-CM 574) between 1997 and 1999 were excluded from our diabetic group. We identified and enrolled 60,734 patients diagnosed with diabetes in 2000.
Control group participants were selected from the list of beneficiaries in 2000 and evaluated to ensure that they were free of diabetes and GSD between 1997 and 2000. The control group comprised 48,116 randomly selected individuals who were age-and sex-matched with the patients in the diabetic group. Cholecystectomy procedures performed between 2000 and 2008 were considered GSD events.
Furthermore, we searched the ambulatory care visit and hospitalization claims information for selected specific comorbidities of hypertension (ICD-9-CM 401, 405), gout (ICD-9-CM 274), hyperlipidemia (ICD-9-CM 272.0e272.9), cystic fibrosis (ICD-9-CM 277.0), sickle-cell disease (ICD-9-CM 282.6), cirrhosis (ICD-9-CM 571.2, 571.5, 571.6), cholangitis (ICD-9-CM 576.1), Caroli disease (ICD-9-CM 576.2), Crohn disease (ICD-9-CM 555.9), and hemolytic anemia (ICD-9-CM 282, 283). The comorbidities were included only when the index date during the study period (2000e2008) was earlier than that of the study endpoint (i.e., GSD) or of censoring.
Patients from the diabetic (n Z 11,326) and control (n Z 8252) groups who had undergone open cholecystectomy (ICD operation 51.22) or LC (ICD operation 51.23) were linked to the inpatient claims between 2000 and 2008 to identify the surgeries to remove gallstones.
Statistical analysis
The sociodemographic variables used in this study were age, sex, occupation, monthly income, and urbanization of the residential area, and these were compared between the diabetic and nondiabetic patients with GSD. To investigate the relationships between variables, univariate and multivariate Cox proportional hazards regression analyses were performed, and these relationships were indicated using adjusted hazard ratios (aHRs) and 95% confidence intervals (95% CIs) for cholecystectomy between the two groups. All analyses were performed using SAS Version 9.1 for Windows (SAS Institute, Inc., Cary, NC, USA). A twotailed value of p < 0.05 was considered statistically significant.
Results
We recruited 60,734 patients with diabetes without prior GSD and 48,116 nondiabetic persons without prior GSD in 2000 from the NHRI datasets in this study ( Table 1 ). The mean AE standard deviation ages were 62.9 AE 11.1 and 62.1 AE 11.3 years for nondiabetic controls and diabetic patients, respectively. Age and sex distributions between the diabetic and control groups were similar, with women accounting for 56.6% of the nondiabetic controls and 55.3% of diabetic patients. In both groups, approximately 50% of participants were aged >64 years, and 45% were aged between 45 and 64 years. Diabetic patients had a slightly lower, but not significantly lower, mean insurance premium than the nondiabetic controls did. The mean preoperative Charlson's Comorbidity Index score was substantially higher for diabetic patients than for nondiabetic controls (1.4 AE 0.8 vs. 0.2 AE 0.5, respectively). Urbanization was prominent in both groups regarding the geographical area, and the geographical distributions between the two groups were similar.
Of the diabetic patients and nondiabetic controls identified in 2000, those who developed symptomatic GSD and underwent cholecystectomy in 2008 are listed in Table 2 . The overall age-and sex-specific incidence density (ID) rates of cholecystectomy in the diabetic patients were higher than those in the nondiabetic controls (45.08 vs. 40.12 per 1000 personeyears, respectively). Of the 60,734 and 48,116 patients in the diabetic and control groups, 11,326 and 8252, respectively, developed GSD and underwent cholecystectomy, with corresponding incidence rates of 18.65% and 17.15%, respectively. Irrespective of the diabetic status, a sex-stratified analysis revealed that men had a higher ID rate of cholecystectomy than women (diabetic men/women: 48.97/42.08 per 1000 patienteyears and control men/women: 42.87/38.12 per 1000 patiente years), and this trend was similar among all age groups. In addition, the ID rates of cholecystectomy were significantly associated with old age irrespective of the diabetic status and sex (Table 2) .
During the 8-year follow-up period, diabetic patients with GSD had higher unadjusted and adjusted incidences of cholecystectomy than those without GSD did (Table 3) . Diabetic patients with GSD were associated with an 11% higher incidence of cholecystectomy in a sociodemographic factor-adjusted analysis than those without GSD (p Z 0.001). In addition, the risk of GSD and subsequent cholecystectomy was higher in patients with hypertension (aHR, 1.12; 95% CI, 1.07e1.16; p < 0.001), cholangitis (aHR, 2.85; 95% CI, 2.75e2.96; p < 0.001), and Caroli disease (aHR, 1.21; 95% CI, 1.11e1.32; p < 0.001) compared with those with other comorbidities, as revealed by the multivariate analysis. By contrast, other comorbidities, such as gout (aHR, 0.96; 95% CI, 0.93e0.99; p Z 0.05), hyperlipidemia (aHR, 0.93; 95% CI, 0.91e0.96; p < 0.001), and cirrhosis (aHR, 1.21; 95% CI, 1.11e1.32; p < 0.001) were associated with a reduced risk of cholecystectomy. The risk of GSD and subsequent cholecystectomy was unaffected by the presence of cystic fibrosis, Crohn disease, and hemolytic anemia.
Discussion
This study provides epidemiological evidence of the incidence of cholecystectomy in the general population of Taiwan. Diabetic patients with GSD had a higher incidence of cholecystectomy than the nondiabetic controls. Men diagnosed with GSD were more likely to undergo cholecystectomy than women in both the diabetic and nondiabetic groups. In addition, the overall incidence of cholecystectomy was associated with increasing age, irrespective of the diabetic status and sex.
An increasing number of studies on animals and humans suggest that insulin resistance and diabetes are associated with organ dysfunction. A combination of diabetes and GSD is a severe condition that requires special care. The pathophysiological features of gallstone formation in patients with diabetes are unclear. Diabetic patients exhibit an increased cholesterol index and reduced gallbladder motility 5 compared with nondiabetic individuals. Furthermore, hyperinsulinemia is associated with an increased prevalence of GSD. 6 Insulin resistance and elevated fasting glucose levels have been associated with gallbladder dysmotility in nondiabetic people, possibly resulting in acalculous cholecystitis or gallstone formation. Consequently, some reports have recommended early cholecystectomy for diabetic patients with asymptomatic gallstones to prevent subsequent serious infection. A large observational study concluded that a mere diagnosis of diabetes is not associated with an increased risk of cholecystectomy. By comparing the risks associated with diabetes duration, serum HbA1c levels, and antidiabetic therapy between diabetic patients and controls, the investigators reported that diabetes was not an independent risk factor for cholecystectomy. 7 Diabetes and male sex are known risk factors for acute cholecystitis and, in general, cholecystitis is more severe in men than in women, even though the cause of severe cholecystitis remains unknown for a high proportion of men. In a previous study comprising 500 patients who had undergone cholecystectomy, 76% of the patients were women 2 ; however, within the acute cholecystitis subset, only 57% of the patients were women. Some reports have indicated that acute cholecystitis is often more fulminant in men than in women, and the higher mortality rate in men than in women may reflect the unwillingness of men to seek medical attention until the disease is at an advanced stage. A recent study reported that men have a higher percentage and conversion rate of acute cholecystitis than women do because of inflammation or bacterial adherence. 8 Women usually exhibit a greater willingness to seek medical attention for mild biliary symptoms than men. Landau et al 3 stated that the higher pain threshold in men compared with women results from delayed presentation at an advanced stage of the disease, and the delay may be caused by psychological and social factors. This finding was further supported by results regarding inflammation and fibrosis in patients with acute cholecystitis, which is more severe in men than in women. Whether the sex-based differences are biological, behavioral, or both, the implications for patient management should be self-evident. An aggressive GSD management approach for men and timely intervention before the need for emergency surgery are recommended. Additional studies are required for further investigation of these differences, which can increase the awareness of the GSD-associated problems and their occurrence in men. Furthermore, the study findings will help in designing health policies for men with GSD and provide favorable diabetes-and GSD-related management approaches for health policy makers and clinicians. The higher rate of GSD-related surgery in the diabetic group compared with the control group may indicate a different presentation of pain symptoms between the two groups, which might be explained by diabetic neuropathy. 9 Diabetic rats exhibited sluggish sensory nerve conduction and a high pain threshold. 10 Evidence has indicated that hyperglycemia may result in changes to the gastric motor and sensory functions, suggesting that any impaired sensory functioning might be related to the dysfunctional control of blood glucose in diabetic patients. Therefore, diabetic patients are likely to be less sensitive to their pain symptoms, and this seems to delay GSD diagnosis until acute and severe cholecystitis develops. This eventually leads to a higher incidence of cholecystectomy in diabetic patients than in nondiabetic controls.
Conclusion
To our knowledge, this is one of the few studies to examine the incidence of cholecystectomy in response to GSD in diabetic patients by using a nationwide populationbased cohort study design. Given the high coverage rate of the NHI system in Taiwan, the likelihood of nonresponse and loss to follow-up are extremely low, ensuring the representativeness of the study participants and the validity of the estimates for the incidence of cholecystectomy in response to GSD. In addition, we have satisfactorily used the longitudinal design of the NHI dataset to follow up on the incidence rates of surgery for GSD in the diabetic and control groups. This study offers a valuable cross-sectional longitudinal analysis of the population pertaining to GSD and diabetes. Future studies are required to identify possible mechanisms related to the association between the presence of diabetes and the increased use of cholecystectomy in GSD treatment. In addition to improving the clinical management of diabetes, our findings will facilitate the development of public policies related to health care services and resource distribution for diabetes and its complications among the general population.
